Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
about
Virtual screening for the discovery of bioactive natural productsThe new generation of monoamine oxidase inhibitorsProtease inhibitors as potential antiviral agents for the treatment of picornaviral infections.Bacteriology at the periphery of the cholera pandemic.Isosterism and bioisosterism in drug design.Combinatorial chemistry: polymer supported synthesis of peptide and non-peptide libraries.Biomimicry as a basis for drug discovery.Biodiversity, chemical diversity and drug discovery.High impact technologies for natural products screening.Application of natural product-inspired diversity-oriented synthesis to drug discovery.Recent advances in immunosuppressants.Present status of hepatoprotectants.The 5-HT1A receptor and its ligands: structure and function.U-50,488 and the kappa receptor: a personalized account covering the period 1973 to 1990.U-50,488 and the kappa receptor. Part II: 1991-1998.Quantitative structure-activity relationships of antihypertensive agents.From genome to drug--optimising the drug discovery process.Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors.Pharmacology of appetite suppression.Neuropeptides in drug research.Regulation of NMDA receptors by ethanol.Troglitazone and emerging glitazones: new avenues for potential therapeutic benefits beyond glycemic control.Applications of developmental biology to medicine and animal agriculture.Crystallins, genes and cataract.Recent advances in prevention and treatment of hepatitis C virus infections.Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters.NMR spectroscopy in drug discovery: tools for combinatorial chemistry, natural products, and metabolism research.Prostate cancer and the androgen receptor: strategies for the development of novel therapeutics.Quantitative structure-activity relationships of cardiotonic agents.The effects of morphine on cell proliferation.Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey.Alternative medicine: herbal drugs and their critical appraisal--Part I.Quantitative structure-activity relationships of antianginal drugs.Purine analogs as CDK enzyme inhibitory agents: a survey and QSAR analysis.Anti-influenza drugs and neuraminidase inhibitors.Current and potential therapies for the treatment of herpesvirus infections.Dioxopiperazines: chemistry and biology.Development of HIV protease inhibitors: a survey.Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection.
P1433
Q28261293-B6AF2103-5A20-4394-B547-7BA5DA9096EBQ28266471-E39E663B-BF13-473F-9113-2687B234DBADQ30322157-E88BF074-5FFE-4509-B81C-FDD9C91BAE24Q30331608-1F73E3C0-9F2D-4A06-A0C3-17C3CFFE33C9Q30444058-CFF574A7-643F-4CC0-A128-E02C208D2DDAQ30829870-CB5CCF69-F2C1-484B-A5EF-6223E6F1E3FBQ31913676-3C51B84D-A219-41D2-9393-36460093DBDDQ33310685-33D23216-BB38-42B4-B05A-0C5BEEFAA343Q33310687-8216B97A-1F68-4BBA-9636-35832919AEEFQ33328602-340AE509-6AFE-45E2-B581-55258FA34CBBQ33681499-387853AC-9AA0-48AC-A8AA-6CF42C124A43Q33681508-965A2570-10BC-40C5-8740-EF6CDD236AAAQ33681514-1AB98768-5C15-425A-9B9D-18497E34CCC6Q33681521-8C82769E-7F77-41D5-A89E-FF2E39CE7977Q33806589-4724444E-2B1D-4C31-8A6D-4D08A0993ED5Q33806594-D3017899-3E58-448C-B349-6BC4F59FB416Q33806599-607228C3-E9C2-42EC-996D-36B3C4306504Q33806603-5E951B0F-6017-4A08-9D58-713C2E33E85AQ33905964-8E6E74FB-03CF-4D3C-A26F-5BD32CDC8F64Q33945287-578546A4-48B9-4E90-B188-142B19A1D7E3Q33945294-958E11BD-5147-4975-8774-6ACB4036D5D1Q33945299-420D81A0-694F-4469-B48E-22B28903CCC1Q33945305-32DC0A6C-FAE5-41ED-B627-B5F2614D8004Q33945310-46A02411-39A7-4C2B-9F9A-520CE171A15EQ33966408-3FD6025D-215F-44A1-98B3-C33C3B475DD6Q34111925-5D2F9151-54C9-4D80-894F-E4AC20404F41Q34111930-65E4823F-1985-4F15-8D0A-44B7329A38C2Q34111933-10D25FA6-2404-4892-A421-C36343C0AAF2Q34111938-49544EB0-A514-43CA-9B5F-40CE97E6E5D9Q34111942-A0FA5E4F-354C-4FF3-95F2-13F49858CFA0Q34111948-C31E6CEC-183E-49CB-9EC0-638613FDD572Q34111954-8CB1709E-CABA-462A-AF86-A581AFCC7103Q34288083-D623076F-B3CE-4C34-B75D-839F6F77806AQ34288091-14C0D495-9277-4955-A9A2-55A989BB7FF7Q34288099-F14CD21D-CFB9-4C77-B08F-7D72320FFBFEQ34288105-46327BEE-8BFC-4C5F-9DAF-CD741C9CA7EFQ34288112-FDF653CF-8AD3-4927-BD50-4DAB156DCB5DQ34295168-5D64F5E6-9166-4093-8251-BB7F729C57CCQ34363071-4F80EDBB-7A98-42D0-BB26-3FA6579867A9Q34363078-1347CA5D-FBA1-4F44-84DA-8A4B6508B133
P1433
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Birkhäuser
@nl
wissenschaftliche Fachzeitschrift
@de
name
Progress in drug research. For ...... des recherches pharmaceutiques
@ast
Progress in drug research. For ...... des recherches pharmaceutiques
@en
Progress in drug research. For ...... des recherches pharmaceutiques
@es
Progress in drug research. For ...... des recherches pharmaceutiques
@it
Progress in drug research. For ...... des recherches pharmaceutiques
@nl
type
label
Progress in drug research. For ...... des recherches pharmaceutiques
@ast
Progress in drug research. For ...... des recherches pharmaceutiques
@en
Progress in drug research. For ...... des recherches pharmaceutiques
@es
Progress in drug research. For ...... des recherches pharmaceutiques
@it
Progress in drug research. For ...... des recherches pharmaceutiques
@nl
altLabel
Prog Drug Res
@en
prefLabel
Progress in drug research. For ...... des recherches pharmaceutiques
@ast
Progress in drug research. For ...... des recherches pharmaceutiques
@en
Progress in drug research. For ...... des recherches pharmaceutiques
@es
Progress in drug research. For ...... des recherches pharmaceutiques
@it
Progress in drug research. For ...... des recherches pharmaceutiques
@nl
P1055
P1156
P123
P1476
Progress in drug research. For ...... des recherches pharmaceutiques
@en